A indústria farmacêutica na judicialização da saúde: percepção dos atores sociais envolvidos
Ano de defesa: | 2017 |
---|---|
Autor(a) principal: | |
Orientador(a): | |
Banca de defesa: | |
Tipo de documento: | Tese |
Tipo de acesso: | Acesso aberto |
Idioma: | por |
Instituição de defesa: |
Universidade Federal de Minas Gerais
UFMG |
Programa de Pós-Graduação: |
Não Informado pela instituição
|
Departamento: |
Não Informado pela instituição
|
País: |
Não Informado pela instituição
|
Palavras-chave em Português: | |
Link de acesso: | http://hdl.handle.net/1843/BUBD-AYFJLT |
Resumo: | The thesis topic had its origin in the search results of masters, which sought to identify factors that could influence the increase of lawsuits in Brazil, concerning the demand for monoclonal antibodies, drugs that have a high cost in the country. The data observed at that moment corroborated by studies conducted both in Minas Gerais and in other states, by researchers who were, in the increase of demands of lawsuits relating to drugs, signs of the enormous influence of the pharmaceutical industry to enter the Brazilian market, new drugs. In order to organise this research, the thesis is structured in the following way: the first chapter is the introduction in which is pointed out the problem and the rationale for the study. The second chapter presents the theoretical frameworks relating to complex medical-industrial complex, health industrial complex and economical-industrial health, as well as the approaches that support the hypotheses on the subject researched. The third chapter presents the theory of Symbolic Interactionism, theoretical-methodological approach that underlies the qualitative methods used in the collection and analysis of data. The chapter also discusses the form of subjects' selection and the process of elaboration and implementation of the interviews. In chapter four are presented the results of the research, with the analysis of the interviews. It is noteworthy that the article about the perception of physicians prescribers about the influence of the pharmaceutical industry in lawsuits is in the appendix of this thesis. Finally, it presents itself in the final chapter of the completion of the dissertation, in which denotes the understanding that the argument of the defense of the right to health, is confused with the need for a drug or medical product, something present in the narratives of the actors involved in lawsuits. This construction generates several consequences, among which, the promotion of a complex phenomenon called Health litigation that feedback by actors involved in this context, much due to the institutional changes that can expand rather than reduce the demands via the judiciary. It is expected that the thesis can generate a reflection not just of researchers who work with the theme, but also of actors who need in your routine in the SUS faces it daily. Despite the limitations of working with a cutout of the theme, i.e., the pharmaceutical industry and its interference in the actions and omissions of the actors in lawsuits, you can have advanced the possibilities of dealing with the phenomenon. |